- Home
- SNES vs TTNP Comparison
SNES vs TTNP Comparison
Compare SNES & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNES
- TTNP
- Stock Information
- Founded
- SNES 2004
- TTNP 1991
- Country
- SNES United States
- TTNP United States
- Employees
- SNES N/A
- TTNP N/A
- Industry
- SNES Agricultural Chemicals
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SNES Industrials
- TTNP Health Care
- Exchange
- SNES Nasdaq
- TTNP Nasdaq
- Market Cap
- SNES 2.9M
- TTNP 3.4M
- IPO Year
- SNES 2016
- TTNP 1996
- Fundamental
- Price
- SNES $1.95
- TTNP $3.73
- Analyst Decision
- SNES Strong Buy
- TTNP
- Analyst Count
- SNES 1
- TTNP 0
- Target Price
- SNES $10.00
- TTNP N/A
- AVG Volume (30 Days)
- SNES 37.9K
- TTNP 29.7K
- Earning Date
- SNES 05-08-2025
- TTNP 05-14-2025
- Dividend Yield
- SNES N/A
- TTNP N/A
- EPS Growth
- SNES N/A
- TTNP N/A
- EPS
- SNES N/A
- TTNP N/A
- Revenue
- SNES $1,857,000.00
- TTNP N/A
- Revenue This Year
- SNES $130.53
- TTNP N/A
- Revenue Next Year
- SNES $80.00
- TTNP N/A
- P/E Ratio
- SNES N/A
- TTNP N/A
- Revenue Growth
- SNES 55.66
- TTNP N/A
- 52 Week Low
- SNES $1.30
- TTNP $3.03
- 52 Week High
- SNES $9.80
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- SNES 49.49
- TTNP 50.05
- Support Level
- SNES $1.30
- TTNP $3.51
- Resistance Level
- SNES $1.75
- TTNP $3.76
- Average True Range (ATR)
- SNES 0.20
- TTNP 0.23
- MACD
- SNES 0.07
- TTNP -0.00
- Stochastic Oscillator
- SNES 75.58
- TTNP 37.31
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.